Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis

BACKGROUND: Clinicians caring for patients with Multiple Sclerosis (MS) need improved biomarkers to aid them in disease management. OBJECTIVE: We assessed the predictive value of the candidate biomarker CXCL13 index in comparison to oligoclonal bands (OCBs) and CSF neurofilament light (NfL) concentr...

Descripción completa

Detalles Bibliográficos
Autores principales: DiSano, Krista D, Gilli, Francesca, Pachner, Andrew R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747124/
https://www.ncbi.nlm.nih.gov/pubmed/33403120
http://dx.doi.org/10.1177/2055217320981396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747124/
https://www.ncbi.nlm.nih.gov/pubmed/33403120
http://dx.doi.org/10.1177/2055217320981396

Ejemplares similares